AMA submission on Electronic recording and reporting of controlled drugs
The AMA supports the development of an electronic system to record and monitor controlled drugs that can be used to help address abuse and misuse of schedule 8 drugs. A project to develop an electronic system is being funded as one of several programs under the Fifth Pharmacy Agreement. The AMA has made a submission to the Department of Health and Ageing in response to a consultation paper released as part of the development phase of the project. The submission notes that any system designed for medical practitioners must be simple, easy to operate and avoid duplication of effort.